Objective-NKT cells promote atherogenesis, but the subtypes responsible have not been identified. We investigated 2 major NKT cell subtypes (CD4 ϩ and DN NKT) in ApoE Ϫ/Ϫ mice rendered NKT cell-deficient by day-3 neonatal thymectomy (3dTx). Methods and Results-Atherosclerosis development was studied in thymectomized ApoE Ϫ/Ϫ mice fed a high-fat diet with/without adoptively transferred NKT cells. We demonstrate NKT cell deficiency in thymectomized mice and markedly smaller atherosclerotic lesions. The reduction in lesion size was reversed by adoptive transfer of liver-derived NKT cells. Adoptive transfer of CD4 ϩ , but not DN NKT cells, into 3dTx ApoE Ϫ/Ϫ mice increased lesion size 2.5-fold. The differential effects were not attributable to differences in homing to developing atherosclerotic lesions. DN NKT cells expressed at least 3-fold higher levels of inhibitory Ly49 receptors (Ly49A, Ly49C/I, and Ly49G2) than CD4 ϩ NKT cells, and lesions expressed large amounts of their MHC class I ligand. In vitro these inhibitory receptors initiated greater effects in DN NKT cells. Culture of each NKT cell subset with TAP-deficient (MHC class I-deficient) dendritic cells and ␣-GalCer led to secretion of similar amounts of proatherogenic cytokines IL-2, IFN-␥, and TNF but, when cultured with MHC class I-positive dendritic cells, CD4 ϩ NKT cells secreted more of these cytokines.
A therosclerosis is a chronic inflammatory disorder that develops at sites of lipid accumulation in large-and medium-sized arteries, which can lead to myocardial infarctions and strokes. The innate and adaptive immune systems are important for atherosclerosis progression with developing lesions being infiltrated by activated T cells and professional antigen presenting cells. 1 Although it has been generally thought that cell-mediated immune responses in atherosclerosis are mostly directed against peptide antigens, 2 recent data indicate that lipid antigens may also be targets of immune responses, particularly those mediated by NKT cells. [3] [4] [5] Invariant NKT cells are a subset of T lymphocytes that coexpress some NK cell markers and recognize glycolipid antigens in the context of the nonpolymorphic MHC class I-related glycoprotein CD1d. 6, 7 NKT cells in mice express semi-invariant T cell receptors (TCRs) with a V␣14-J␣18 ␣-chain preferentially associated with either V␤8.2, V␤7 or V␤2 ␤-chains. 8 On stimulation, these cells have the capacity to secrete large amounts of cytokines, including IFN-␥ and IL-4, and cause bystander activation of other immune cells including NK cells, B cells and CD8 ϩ T-cells. 9, 10 Lipid antigens can be presented to NKT cells as a complex with the CD1d molecule. The natural lipid ligands for activation of CD1d-restricted NKT cells remain unclear. Although isoglobotrihexosylceramide (iGb3) is the best candidate for an agonist ligand, controversy exists as to whether it is the primary ligand for NKT cells. The glycolipid ␣-galactosylceramide (␣-GalCer), derived from marine sponge, specifically activates NKT cells and modulates a wide range of immune responses, including autoimmune diseases, antitumor responses, defense against pathogens, and allergy. 9, 11 NKT cells have been identified in human atherosclerotic lesions. 12 In mice, their activation by ␣-GalCer markedly increased lesion development with early increases in proinflammatory cytokines such as IFN-␥, TNF, and IL-2. 3 Absence of NKT cells attributable to CD1d deficiency was associated with reduced atherosclerotic lesion size. These studies indicate that NKT cells exacerbate the atherogenic process. [3] [4] [5] NKT cells can be subdivided into two major subsets, CD4 ϩ and CD4-CD8-(DN) NKT cells that produce different cytokines on activation in humans and mice. [13] [14] [15] In mice, these two populations differentially affect antitumor immunity, with liver-derived DN NKT cells being more efficient at rejecting sarcoma and melanoma cell lines than CD4 ϩ NKT cells. 16 However, the role of NKT cell subsets in the development of atherosclerosis has not previously been addressed.
Here, we investigated the potential of these NKT cell subtypes to exacerbate atherosclerosis, by adoptively transferring each subtype into ApoE Ϫ/Ϫ mice rendered NKT cell-deficient by neonatal thymectomy.
Methods

Mice
ApoE Ϫ/Ϫ and TAP Ϫ/Ϫ mice (backcrossed to C57BL/6J background for 10 generations) were obtained from the Walter and Eliza Hall Institute (WEHI, Melbourne, Australia). ApoE Ϫ/Ϫ mice were bred at the AMREP Animal Centre. Ly5.1 (C57Bl6) mice were obtained from WEHI (Monash Animal Services, Clayton, Australia), and Animal Resources Centre (Western Australia, Australia). Three-dayold ApoE Ϫ/Ϫ mice were subjected to either sham operation or thymectomy, then at 5 to 6 weeks of age they received NKT cells and were fed a high fat diet consisting of 21% butter fat and 0.15% cholesterol (Specialty Feeds) for 8 weeks. Thereafter mice were killed with an overdose of pentobarbitone (120 mg/kg ip), blood collected by cardiac puncture, and aortic sinus and arch collected for histology and molecular biology studies. All experiments were approved by the Alfred Medical Research Education Precinct (AMREP) Animal Ethics Committee.
For expanded Materials and Methods used in this article, please see the supplemental materials (available online at http:// atvb.ahajournals.org).
Results
NKT Cell Depletion by Neonatal Thymectomy Ameliorates Atherosclerosis
To confirm that neonatal thymectomy depleted ApoE Ϫ/Ϫ mice of NKT cells, liver lymphocytes and blood from these mice were subjected to flow cytometric analysis using CD1d/ ␣-GalCer tetramers and TCR antibodies. In the liver, neonatal thymectomy reduced NKT cells in 14-week-old ApoE Ϫ/Ϫ fed a high-fat diet by approximately 90% (sham 15.82Ϯ1.522% versus thymectomy 1.73Ϯ0.43%, Figure 1A ). In blood, no NKT cells could be detected in thymectomized mice ( Figure  1 ). To assess the effect of 3dTx on numbers of other major lymphocyte populations, splenocytes were stained for CD4 ϩ T cells, CD8 ϩ T cells, and B cells, and analyzed by flow cytometry. No significant differences in cell numbers were found between thymectomized and sham-operated mice (supplemental Table I ). To determine whether atherosclerotic lesions in ApoE Ϫ/Ϫ mice were also depleted of NKT cells, we assessed by RT-PCR the expression of the invariant V␣14-J␣18 ␣-chain specific to NKT cells. Analysis of mRNA from lesions of nonthymectomized ApoE Ϫ/Ϫ mice by RT-PCR resulted in the expected product of 70 bp, indicating the presence of NKT cells in lesions ( Figure 1B) . In contrast, the product amplified from mRNA from lesions of thymectomized mice was barely detectable. To confirm these observations, mRNA was also subjected to real-time PCR analysis. By real-time PCR, V␣14-J␣18 ␣-chain mRNA was undetectable in thymectomized mice (Ct [ie, cycle threshold]Ͼ45 compared to Ctϭ37 in sham thymectomized mice; L7 [housekeeping gene] Ctϭ26). Thus thymectomy of ApoE Ϫ/Ϫ mice at 3 days after birth resulted in marked NKT cell depletion in the periphery and in developing atherosclerotic lesions.
Depletion of NKT cells by neonatal thymectomy was also associated with a marked attenuation of atherosclerotic lesion development, despite concomitant depletion of Foxp3 ϩ regulatory T cells in atherosclerotic lesions (data not shown), which has been shown to aggravate atherosclerosis. 17 After 8-weeks on a high-fat diet, atherosclerotic lesions measured using Oil Red O staining was reduced by 52% in the thymectomized mice (PϽ0.05; Figure 2A ). Similarly, macrophage accumulation was also reduced in these mice by 59% (PϽ0.05; Figure 2B ), whereas collagen content doubled (PϽ0.05; Figure 2C ). However, intimal smooth muscle cell (SMC) and CD4 ϩ and CD8 ϩ T-cell populations were unaffected (PϾ0.05; supplemental Table II ).
CD4 ؉ but Not DN NKT Cells Promote Atherogenesis in ApoE ؊/؊ Mice
To investigate whether the effects of thymectomy on development of atherosclerosis were a consequence of NKT cell depletion, we assessed the effects of adoptively transferring unfractionated NKT cells into thymectomized ApoE Ϫ/Ϫ mice. Adoptive transfer of 3ϫ10 5 NKT cells, one week before commencing mice on the high-fat diet, reversed the effects of thymectomy on development of atherosclerosis. Adoptive transfer of NKT cells increased lesion size at the aortic sinus by 229% (PϽ0.05; Figure 3A ) and macrophage accumulation by 218% (PϽ0.05; Figure 3B ). Collagen content was not significantly altered, although there was a tendency for it to be reduced in adoptively transferred mice (PϾ0.05; Figure 3C ). SMC and T-cell populations were unaffected (supplemental Table II ). Because NKT cell sub- sets have been shown to differentially affect tumor growth in mice, 16 we next sought to determine whether they might also differentially affect development of atherosclerotic lesions. Hepatic CD4 ϩ and DN NKT cells were isolated by flow cytometry, and each purified cell population was transferred into thymectomized ApoE Ϫ/Ϫ mice fed a high-fat diet (supplemental Figure I ). Adoptive transfer of CD4 ϩ NKT cells into thymectomized mice increased aortic sinus lesion size by 240% (PϽ0.05; Figure 3A) , with macrophage accumulation also markedly increased by 244% (PϽ0.05; Figure  3B ) and collagen content reduced by 27% (PϽ0.05; Figure  3C ). In contrast, adoptive transfer of identical numbers of DN NKT cells did not affect lesion size or accumulation of macrophages within developing lesions (PϾ0.05; Figure  3A and 3B), but reduced collagen content in lesions by 38% (PϽ0.05; Figure 3C ). Transfer of either NKT cell subtype tended to reduce the number of CD4 ϩ T lymphocytes in developing lesions, but the difference was not statistically significant (PϾ0.05; supplemental Table II ). The apparent higher numbers of CD4 ϩ and CD8 ϩ T cells in lesions of thymectomized mice was attributable to cell counts being adjusted for the size of lesions that were considerably smaller in these mice. Smooth muscle cells were unaffected (PϾ0.05; supplemental Table II ). To exclude the possibility that one NKT subset was more capable of homing to lesions than the other, we adoptively transferred Ly5.1 ϩ CD4 ϩ or DN NKT cells into atherosclerotic Ly5.2 ϩ thymectomized ApoE Ϫ/Ϫ mice and examined for Ly5.1 ϩ cells in lesions 16 to 24 hours after transfer. Only small numbers of adoptively transferred NKT cells entered the lesions, consistent with them being a minor cell population in atherosclerotic lesions (supplemental Figure II ). We found no difference in the number of Ly5.1 ϩ cells detected in lesions from mice transferred with either subset [4.4Ϯ1.1 CD4 ϩ NKT cells/10 sections (nϭ8) versus 7.7Ϯ2.0 DN NKT cells per 10 sections (nϭ6); PϾ0.05] (supplemental Figure II) .
Plasma Cholesterol Levels Do Not Account for the Differential Proatherogenic Activity of NKT Cell Subtypes
To exclude any confounding effects of changes in plasma cholesterol on development of atherosclerosis in the NKT cell depletion and adoptive transfer models of atherosclerosis we measured plasma cholesterol levels at the end of the 8-week high-fat diet, and found them to be similar in the different groups of mice (Ϸ25 mmol/L, PϾ0.05; supplemental Table  III ). Body weights were also similar in the different groups of mice (supplemental Table III ). 
Cytokine Production by Anti-CD3 Stimulated NKT Cell Subtypes
To determine whether the differential effects of the NKT cell subtypes were attributable to differential production of proinflammatory cytokines, we examined their ability to produce cytokines after in vitro stimulation with anti-CD3 antibodies. Twenty-four hours after stimulation with anti-CD3, DN NKT cells produced greater amounts of the inflammatory cytokines, IFN-␥, TNF, and IL-2 compared to CD4 ϩ NKT cells (supplemental Figure III) . Analysis of mRNA from the two cell types also indicated that DN NKT cells produced greater quantities of proinflammatory cytokines. Compared to CD4 ϩ NKT cells, IFN-␥ mRNA was elevated 3-fold in DN-NKT cells, macrophage migratory inhibitory factor was elevated 2-fold, and GM-CSF, 4-fold; expression of lower abundance cytokines such as lymphotoxin ␣ and TNFSF11 (RANKL) were also greater in anti-CD3 stimulated DN-NKT cells, whereas IL-12a expression was greater in CD4 ϩ NKT cells (supplemental Figure III) . Together, these data suggest that additional mechanisms regulate the effects of the two NKT cell subtypes on development of atherosclerosis.
DN NKT Cells Express Higher Levels of Ly49 Inhibitory Receptors
The extent of NKT cell activation is not only dependent on ligands interacting with their activating CD1-restricted T-cell receptors but also on inhibitory receptors, NKG2A and receptors of the Ly49 family. 18, 19 NKT cell subtypes have previously been shown to differentially express Ly49 inhibitory receptors. 19 Consequently, we examined in ApoE Ϫ/Ϫ mice whether liver-derived CD4 ϩ NKT and DN NKT cells differed in their expression of Ly49A, Ly49C/I, and Ly49G2 inhibitory receptors. Flow cytometric analysis of electronically gated CD4 ϩ NKT and DN NKT cells indicated expression of these inhibitory receptors by DN NKT cells were at least 3 times greater than by CD4 ϩ NKT cells (Ly49A: 22.5Ϯ1.8% on DN NKT cells versus 6.6Ϯ1.2% on CD4 ϩ NKT cells; Ly49C/I: 8.3Ϯ0.7% on DN NKT cells versus 2.6Ϯ0.3% on CD4 ϩ NKT cells; Ly49G2: 11.3Ϯ0.8% on DN NKT cells versus 0.7Ϯ0.1% on CD4 ϩ NKT cells, PϽ0.05) (supplemental Figure IV ), suggesting that DN NKT cells may be more susceptible to inhibition by MHC class I ligands.
Aortic Lesions Overexpress Ly49 Inhibitory Receptor Ligand MHC Class I
Overexpression of Ly49 inhibitory receptors on DN NKT cells relative to CD4 ϩ NKT cells could explain their differential abilities to augment development of atherosclerosis, particularly if developing lesions overexpressed MHC class I proteins; MHC class I proteins are major ligands for inhibitory Ly49 receptors. 20 Hence we next examined atherosclerotic lesions for the expression of MHC class I. We found that MHC class I proteins were markedly elevated in atherosclerotic lesions compared to surrounding tissues and nondiseased vessels (supplemental Figure V) . This indicates that ample levels of MHC class I proteins are present in lesions to interact with inhibitory Ly49 receptors differentially expressed by NKT cell subtypes. Costaining for MHC class I with smooth muscle cells or macrophages, the two main cell types in atherosclerotic lesions, indicated that macrophages were an important cell type in atherosclerotic lesions expressing MHC class I (supplemental Figure V) . 
Ly49 Inhibitory Receptors Regulate Proinflammatory Cytokine Production by NKT Cell Subsets
To examine whether Ly49 inhibitory receptors influenced the proatherogenic properties of the two NKT cell subtypes, we examined their ability to secrete proinflammatory cytokines in the presence and absence of MHC class I. Stimulation of NKT cells with ␣-GalCer in the presence of dendritic cells from MHC class I-deficient TAP-deficient mice resulted in elevation of IL-2, IFN-␥, and TNF secretion by both cell subtypes to a similar extent (Figure 4 ). However, when these cells were stimulated in the presence of dendritic cells from ApoE Ϫ/Ϫ mice, which express MHC class I, CD4 ϩ NKT cells became the more proinflammatory cell type. Secretion of IL-2, IFN-␥, and TNF by CD4 ϩ NKT cells was 2-fold, 5-fold, and 2-fold higher, respectively, compared to DN NKT cells ( Figure 4A ). To further confirm that higher expression of Ly49 inhibitory receptors, specifically Ly49C and Ly49I on DN NKT cells was responsible for reduced production of inflammatory cytokines in the presence of MHC class I, CD4 ϩ and DN NKT cells were stimulated with ␣-GalCer in the presence of dendritic cells and blocking Ly49C/I antibodies. As expected, addition of Ly49C/I-blocking antibodies to culture increased cytokine production by both NKT cell subsets. However, the relative increase in cytokine production was greater for DN NKT cells compared to CD4 ϩ NKT cells, (IFN-␥ secretion 20% increase for CD4 ϩ NKT cells versus 50% increase for DN NKT cells; TNF production 11% increase for CD4 ϩ NKT cells versus 31% for DN NKT cells; Figure 4B ), consistent with the larger number of Ly49C/I receptors on DN NKT cells having a greater inhibitory effect.
Discussion
NKT cells are CD1d-restricted T cells that mediate both protective and regulatory immune functions. These cells comprise several subtypes, but the extent to which the different subtypes perform distinct functions in vivo is still unclear. In the present study, we used a novel adoptive transfer model of atherosclerosis in ApoE Ϫ/Ϫ mice depleted of NKT cells to demonstrate that subtypes of NKT cells exhibit differential function in atherosclerosis development. We found that CD4 ϩ but not DN (CD4-CD8-) NKT cells augment the development of atherosclerosis. Differences in their proatherogenic activity appeared to be associated with their differential expression of Ly49 inhibitory receptors, which can be activated by MHC class I proteins. 20 In this context, we found the MHC class I molecule to be highly overexpressed in developing atherosclerotic lesions. This is the first study to identify CD4 ϩ NKT cells and not DN NKT cells as the proatherogenic subtype. However, we found that DN NKT cells produced greater amounts of proinflammatory cytokines after anti-CD3 stimulation in vitro, yet it is the CD4 ϩ NKT and not DN NKT cells that promoted atherosclerosis by augmenting lesion expansion in vivo. Because homing to lesions was similar, we asked whether the lack of proinflammatory activity of the DN subset in vivo could be accounted for by their inhibition in the in vivo setting. To address this, we examined both subsets for differential expression of inhibitory receptors that may explain this discrepancy. The DN subset did indeed express more abundant inhibitory Ly49 receptors compared to the CD4 ϩ NKT cell subtype. In vitro, the ability of the DN subtype to produce the proatherogenic cytokines IL-2, IFN-␥, and TNF 21-23 after stimulation with ␣-GalCer in vitro was reduced when they were cultured with antigen presenting dendritic cells from wild-type ApoE Ϫ/Ϫ mice that express MHC class I, but not when cultured with antigen presenting dendritic cells from TAP Ϫ/Ϫ mice, which lack MHC class I. In these experiments, we used dendritic cells as the antigenpresenting cell as they express high levels of MHC class I 24 and are present in significant numbers in atherosclerotic lesions. 25 Our findings are consistent with the report that expression of MHC class I on antigen presenting cells has inhibitory effects on the activation of Ly49-expressing NKT cells. 26 In vivo, we found overexpression of the MHC class I molecule, largely by macrophages in atherosclerotic lesions compared to undetectable levels of this molecule in nonatherosclerotic aortas. The abundant overexpression of MHC class I in atherosclerotic lesions in vivo provides a plausible explanation for the differential proatherogenic activity of the CD4 ϩ compared to the DN NKT cell subtype in developing lesions. These findings suggest that MHC class I interaction with inhibitory Ly49 receptors in vivo inhibits the proatherogenic activity of DN NKT cells. This is supported by our finding that in the presence of blocking Ly49C/I antibodies, the relative increase in cytokine production was greater for DN NKT cells compared to CD4 ϩ NKT cells. Our finding that CD4 ϩ but not DN NKT cells augment development of atherosclerosis is consistent with recent findings of the differential effects of human NKT cell subtypes on activating lymphocytes implicated in atherosclerosis. Human CD4 ϩ NKT cells cocultured with peripheral blood mononuclear cells demonstrated substantially greater stimulatory activities on CD4 ϩ T cells, NK cells, and B cells than other NKT cell subsets. Our finding that both subtypes exhibited similar homing to lesions is consistent with our finding that adoptive transfer of the two subsets exerted similar effects on lesion collagen content. Survival times for adoptively transferred NKT cell subsets has also been reported to be similar, up to 8-weeks after transfer. 16 There were also no differences in total plasma cholesterol levels as a result of any treatment, consistent with previous findings of a lack of effect of NKT cells on plasma cholesterol levels and plasma lipoprotein (VLDL, LDL, and HDL) profiles. 27, 28 Our study confirms and extends previous studies demonstrating proatherogenic effects of NKT cells. [3] [4] [5] [27] [28] [29] In contrast to previous studies, which used either CD1d-deficient ApoE Ϫ/Ϫ or LDLR Ϫ/Ϫ mice, we depleted NKT cells by subjecting 3-day-old ApoE Ϫ/Ϫ mice to thymectomy. 30 It should be noted that neonatal thymectomy also depletes naturally occurring Foxp3 ϩ regulatory T cells, 31 and we have confirmed the depletion of these cells in the atherosclerotic lesions of the thymectomised mice (data not shown). However, our data showing that neonatal thymectomy reduced atherosclerotic lesion size suggests that changes in lesion development are likely to be attributable to NKT cell depletion, as deficiency of Foxp3 ϩ regulatory T cells has been shown to accelerate lesion development. 17 This suggestion was confirmed by the observation that adoptive transfer of unfractionated NKT cells just before feeding mice a high-fat diet reversed the effects of thymectomy on development of atherosclerotic lesions. Our findings are consistent with reports that atherosclerosis was reduced in mice rendered NKT cell-deficient by J␣18 deficiency, 28 whereas adoptive transfer of NKT cells from J␣18 T cell receptor transgenic mice to Rag Ϫ/Ϫ immunodeficient mice aggravated atherosclerosis. 32 Our data are also consistent with the observation that administration of ␣-GalCer, a synthetic glycolipid that activates NKT cells via CD1d, further augments atherosclerosis. 3, 5 Our finding that adoptive transfer of nonactivated NKT cells augments atherosclerosis suggests that these cells are activated in vivo by endogenous ligands. While endogenous ligands responsible for activating NKT cells are still to be identified, 33, 34 it has been suggested that hyperlipidemic serum may contain such ligands, and oxidized low-density lipoproteins have been shown to activate hepatic mononuclear cells in a CD1d-dependent manner. 5 Activation of NKT cells with ␣-GalCer has previously been shown to reduce collagen levels in developing atherosclerotic lesions of LDLR Ϫ/Ϫ mice. 5 In the present study we show that CD4 ϩ and DN NKT cells are equipotent in relation to their ability to reduce collagen in developing atherosclerotic lesions, indicating that this effect is independent of their differential expression of Ly49 inhibitory receptors or inflammatory cytokines such as IFN-␥, which are known to attenuate collagen biosynthesis. 21 Whether NKT cells affect lesion collagen content by directly attenuating collagen synthesis, or by augmenting collagen degradation, requires further study. The expression of lysyl oxidase, an enzyme responsible for stabilizing collagen by forming lysine and hydroxyl-lysine cross-links in collagen, 35 was similar in lesions after adoptive transfer of CD4 ϩ or DN NKT cells (data not shown). It has been suggested that the contribution of CD1d-reactive NKT cells to lesion development occurs in the very early stages of lesion development, possibly during the formation of fatty streaks, as these cells do not affect the cytokine milieu or the degree of inflammation in advanced lesions. 27 Although the time course of collagen accumulation in relation to development of atherosclerosis in ApoE Ϫ/Ϫ mice has not been investigated, in humans, collagen accumulation is mostly associated with development of atheroma, occurring in fibrous plaques rather than within fatty streaks. 36 Hence it is likely that NKT cell effects on collagen are not restricted to fatty streaks but rather occur throughout lesion development. Together this differential pattern of effects of NKT cells on lesion development and collagen further support the involvement of two independent mechanisms by which NKT cells affect lesion progression and collagen accumulation.
In conclusion, our study describes novel differential effects of NKT cell subtypes on the development of atherosclerosis. We show that CD4 ϩ NKT cells have proatherogenic activity, whereas the proatherogenic potential of DN NKT cells appears to be limited by their higher expression of inhibitory Ly49 receptors.
